Variant report

Variant	nsv916666
Chromosome Location	chr3:241075-380279
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:573)
CpG islands
(count:732)
Chromatin interactive
region (count:11)
LncRNA
region (count:6)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:573 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr3:305517-307368	HepG2	liver:	n/a	n/a
2	ARID3A	chr3:291259-291870	HepG2	liver:	n/a	n/a
3	ATF2	chr3:319964-320748	GM12878	blood:	n/a	n/a
4	ATF2	chr3:331761-332103	GM12878	blood:	n/a	n/a
5	ATF2	chr3:319829-320847	GM12878	blood:	n/a	n/a
6	ATF2	chr3:254017-254518	GM12878	blood:	n/a	n/a
7	ATF2	chr3:254098-254530	GM12878	blood:	n/a	n/a
8	ATF3	chr3:306304-306760	A549	lung:	n/a	n/a
9	BACH1	chr3:271174-271333	K562	blood:	n/a	n/a
10	BATF	chr3:341729-341996	GM12878	blood:	n/a	n/a
11	BATF	chr3:320384-320805	GM12878	blood:	n/a	n/a
12	BATF	chr3:254085-254416	GM12878	blood:	n/a	n/a
13	BATF	chr3:319974-320310	GM12878	blood:	n/a	n/a
14	BATF	chr3:259675-259847	GM12878	blood:	n/a	n/a
15	BATF	chr3:319906-320293	GM12878	blood:	n/a	n/a
16	BCL11A	chr3:319942-320280	GM12878	blood:	n/a	chr3:320201-320210 chr3:320061-320069
17	BCL11A	chr3:319927-320341	GM12878	blood:	n/a	chr3:320201-320210 chr3:320061-320069
18	BCL3	chr3:306168-306863	A549	lung:	n/a	chr3:306285-306294 chr3:306282-306291
19	BCL3	chr3:320464-320727	GM12878	blood:	n/a	n/a
20	BCL3	chr3:306315-306750	A549	lung:	n/a	n/a
21	BCLAF1	chr3:320388-320763	GM12878	blood:	n/a	n/a
22	BHLHE40	chr3:319378-320826	GM12878	blood:	n/a	n/a
23	BHLHE40	chr3:260263-260618	GM12878	blood:	n/a	n/a
24	BHLHE40	chr3:260829-261058	GM12878	blood:	n/a	n/a
25	BHLHE40	chr3:306286-306823	HepG2	liver:	n/a	n/a
26	BHLHE40	chr3:342270-342502	GM12878	blood:	n/a	n/a
27	BRCA1	chr3:306367-306903	Hela-S3	cervix:	n/a	n/a
28	BRCA1	chr3:306406-306600	HepG2	liver:	n/a	n/a
29	CEBPB	chr3:306331-306724	HepG2	liver:	n/a	chr3:306463-306480
30	CEBPB	chr3:242488-242808	A549	lung:	n/a	n/a
31	CEBPB	chr3:306282-306969	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
32	CEBPB	chr3:291583-291816	HepG2	liver:	n/a	chr3:291705-291716
33	CEBPB	chr3:306264-306872	IMR90	lung:	n/a	chr3:306309-306322 chr3:306463-306480
34	CEBPB	chr3:284758-286178	IMR90	lung:	n/a	chr3:284916-284933 chr3:285984-286001 chr3:284887-284900
35	CEBPB	chr3:306278-306814	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
36	CEBPB	chr3:302689-302981	Hela-S3	cervix:	n/a	chr3:302812-302825
37	CEBPB	chr3:242447-242817	IMR90	lung:	n/a	n/a
38	CEBPB	chr3:279116-279413	HepG2	liver:	n/a	chr3:279226-279239 chr3:279227-279238
39	CEBPB	chr3:306097-307016	A549	lung:	n/a	chr3:306309-306322 chr3:306463-306480
40	CEBPB	chr3:243949-244303	HepG2	liver:	n/a	chr3:244109-244120
41	CEBPB	chr3:306243-306864	HepG2	liver:	n/a	chr3:306309-306322 chr3:306463-306480
42	CEBPB	chr3:306266-306559	MCF-7	breast:	n/a	chr3:306309-306322 chr3:306463-306480
43	CEBPB	chr3:271018-271333	H1-hESC	embryonic stem cell:	n/a	chr3:271305-271317
44	CEBPB	chr3:243976-244300	IMR90	lung:	n/a	chr3:244109-244120
45	CEBPB	chr3:291612-291803	H1-hESC	embryonic stem cell:	n/a	chr3:291705-291716
46	CEBPB	chr3:377988-378086	H1-hESC	embryonic stem cell:	n/a	n/a
47	CEBPB	chr3:243974-244307	A549	lung:	n/a	chr3:244109-244120
48	CEBPB	chr3:242454-242771	H1-hESC	embryonic stem cell:	n/a	n/a
49	CEBPB	chr3:242500-242742	K562	blood:	n/a	n/a
50	CEBPB	chr3:320077-320362	HepG2	liver:	n/a	chr3:320218-320229

(count:732 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr3:350789-350839	HCF	heart:	n/a
2	chr3:350682-350732	NB4	blood:	n/a
3	chr3:241182-241232	HCT-116	colon:	n/a
4	chr3:350892-350942	K562	blood:	n/a
5	chr3:350503-350553	HUVEC	blood vessel:	n/a
6	chr3:347869-347919	AG10803	skin:	n/a
7	chr3:350503-350553	Jurkat	blood:	n/a
8	chr3:353166-353216	HPAEpiC	pulmonary alveolar:	n/a
9	chr3:285234-285284	SAEC	small airway:	n/a
10	chr3:350892-350942	SK-N-MC	brain:	n/a
11	chr3:350892-350942	PANC-1	pancreas:	n/a
12	chr3:347869-347919	SK-N-SH_RA	brain:	n/a
13	chr3:350789-350839	GM12892	blood:	n/a
14	chr3:353166-353216	HCM	heart:	n/a
15	chr3:350789-350839	K562	blood:	n/a
16	chr3:350503-350553	GM06990	blood:	n/a
17	chr3:350892-350942	HCPEpiC	choroid plexus:	n/a
18	chr3:347869-347919	PANC-1	pancreas:	n/a
19	chr3:350789-350839	AG09309	skin:	n/a
20	chr3:351003-351053	HL-60	blood:	n/a
21	chr3:347869-347919	ovcar-3	ovarian:	n/a
22	chr3:243996-244046	Hela-S3	cervix:	n/a
23	chr3:347869-347919	AG09319	gingival:	n/a
24	chr3:353166-353216	HCPEpiC	choroid plexus:	n/a
25	chr3:241182-241232	ovcar-3	ovarian:	n/a
26	chr3:350682-350732	HMEC	breast:	n/a
27	chr3:350503-350553	GM12892	blood:	n/a
28	chr3:347869-347919	Hepatocyte	liver:	n/a
29	chr3:243996-244046	MCF10A-Er-Src	breast:	n/a
30	chr3:271185-271235	MCF10A-Er-Src	breast:	n/a
31	chr3:243996-244046	HL-60	blood:	n/a
32	chr3:347869-347919	U87	brain:	n/a
33	chr3:347869-347919	NHDF-neo	bronchial:	n/a
34	chr3:350602-350652	PFSK-1	brain:	n/a
35	chr3:271185-271235	NT2-D1	testis:	n/a
36	chr3:243996-244046	HEK293	kidney:	embryo
37	chr3:350892-350942	HRPEpiC	eye:	n/a
38	chr3:285234-285284	HNPCEpiC	eye:	n/a
39	chr3:350503-350553	SAEC	small airway:	n/a
40	chr3:241182-241232	NT2-D1	testis:	n/a
41	chr3:285234-285284	ovcar-3	ovarian:	n/a
42	chr3:353166-353216	MCF-7	breast:	n/a
43	chr3:350682-350732	LNCaP	prostate:	n/a
44	chr3:350789-350839	NH-A	brain:	n/a
45	chr3:350602-350652	NH-A	brain:	n/a
46	chr3:350602-350652	HMEC	breast:	n/a
47	chr3:350682-350732	GM12891	blood:	n/a
48	chr3:351003-351053	Hepatocyte	liver:	n/a
49	chr3:285234-285284	HCM	heart:	n/a
50	chr3:271185-271235	HPAEpiC	pulmonary alveolar:	n/a

(count:11 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:
2	chr3:321596..323780-chr3:337949..340526,2	MCF-7	breast:
3	chr3:333238..334968-chr3:337821..339342,2	MCF-7	breast:
4	chr3:321596..323780-chr3:337949..340526,2	MCF-7	breast:
5	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
6	chr3:379607..381981-chr3:384960..386643,2	K562	blood:
7	chr3:297411..299702-chr3:300779..302869,2	K562	blood:
8	chr3:297411..299702-chr3:300779..302869,2	K562	blood:
9	chr3:291331..293955-chr3:294697..297452,2	MCF-7	breast:
10	chr3:369627..372241-chr3:375088..376630,2	K562	blood:
11	chr3:369627..372241-chr3:375088..376630,2	K562	blood:

(count:6 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087560
2	lnc-CNTN6-7	chr3:288251-290282	NONHSAT087561
3	lnc-CNTN6-7	chr3:254887-255362	NONHSAT087562
4	lnc-IL5RA-15	chr3:350397-351005	NONHSAT087564
5	lnc-CNTN6-7	chr3:286296-286375	NONHSAT087561
6	lnc-CNTN6-7	chr3:288251-288539	NONHSAT087560

No data

Variant related genes	Relation type
RNU6-1194P	TF binding region
RPS8P6	TF binding region
CHL1-AS2	TF binding region
CHL1	TF binding region
RNU6-1194P	CpG island
RPS8P6	CpG island
CHL1-AS2	CpG island
CHL1	CpG island

Extended variants
information (count: 7013 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:7013 , 50 per page) page: 1 2 3 4 5 6 7 ... 141

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557163653	chr3:241075-241076	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs575638511	chr3:241078-241079	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs546219281	chr3:241094-241095	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs564432743	chr3:241133-241134	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs563864907	chr3:241134-241135	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs528810269	chr3:241148-241149	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs540900048	chr3:241174-241175	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs562334015	chr3:241182-241183	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs529451201	chr3:241183-241184	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs149015677	chr3:241196-241197	Weak transcription Enhancers Bivalent/Poised TSS Active TSS Flanking Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs184421557	chr3:241204-241205	Weak transcription Enhancers Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs568857306	chr3:241228-241229	Weak transcription Enhancers Active TSS	CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs189077598	chr3:241259-241260	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs142911602	chr3:241309-241310	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs115896018	chr3:241315-241316	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs533859036	chr3:241323-241324	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs181797091	chr3:241340-241341	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs567492842	chr3:241374-241375	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs530928649	chr3:241411-241412	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs111962547	chr3:241422-241423	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs560145796	chr3:241423-241424	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs141355310	chr3:241468-241469	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs527403975	chr3:241480-241481	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs114506283	chr3:241506-241507	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs185513039	chr3:241529-241530	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs558204991	chr3:241532-241533	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs190823682	chr3:241559-241560	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs17329226	chr3:241572-241573	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs562236467	chr3:241575-241576	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs574222812	chr3:241577-241578	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs376626866	chr3:241598-241599	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs180784868	chr3:241631-241632	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs544482348	chr3:241669-241670	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs368804496	chr3:241673-241674	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs76419249	chr3:241708-241709	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs553154620	chr3:241721-241722	Weak transcription Enhancers Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs547587353	chr3:241867-241868	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs563060365	chr3:241893-241894	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs17329247	chr3:241913-241914	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
40	rs551035440	chr3:241920-241921	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs559745938	chr3:241967-241968	Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs527280254	chr3:242054-242055	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs549303189	chr3:242090-242091	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs73088630	chr3:242109-242110	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs538099927	chr3:242117-242118	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs376349970	chr3:242147-242148	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs531860383	chr3:242149-242150	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs571391055	chr3:242152-242153	Weak transcription Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs138886121	chr3:242222-242223	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs550092663	chr3:242227-242228	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Cancer	20164920	CNVD
Lung cancer	16618734	CNVD
Autism	18349135	CNVD
Breast cancer	20409316	CNVD
Myelofibrosis	22110671	CNVD
Autism	22241247	CNVD
Intellectual disability	22045946	CNVD
Squamous cell cancer	19607727	CNVD
Gastric adenocarcinoma	19115996	CNVD
sporadic birth defects	19047251	CNVD
Mental retardation	17124404	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Sudden cardiac death	19188705	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Papillary thyroid carcinoma	21436994	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Breast cancer	17603634	CNVD
Neuroblastoma	17327916	CNVD
Glioblastoma multiforme	21080181	CNVD
Colorectal cancer	21297112	CNVD
Lynch syndrome	18415027	CNVD
Renal cell carcinoma	18592004	CNVD
Acute myeloid leukemia	20729466	CNVD
Urothelial carcinoma	18382360	CNVD
Melanoma	18172304	CNVD
Cervical cancer	21062161	CNVD
Hirschsprung''s Disease	21712996	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Insulin resistance	16721378	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Ewing''s sarcoma	21437220	CNVD
Neuroblastoma	21484798	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Oral cancer	19627613	CNVD
Renal cell carcinoma	19461508	CNVD
Epithelial cancer	22065749	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Acute myeloid leukemia	16864856	CNVD
Liposarcoma	21253554	CNVD
Basal cell lymphoma	21115979	CNVD
Endometrial cancer	22040021	CNVD
Pancreatic endocrine tumor	20981439	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	17387387	CNVD
Oral cancer	21386901	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Retinoblastoma	21504564	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	20967226	CNVD
Autism	22543975	CNVD
Attention deficit hyperactivity disorder	19546859	CNVD
lymphocytic leukemia	21291569	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	17289997	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	21668985	CNVD
Tetralogy of Fallot	22912587	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	20685689	CNVD
Melanoma	20877625	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Hodgkin''s lymphoma	17606441	CNVD

Chromatin state (count:540 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:237400-241200	Active TSS	Brain Inferior Temporal Lobe	brain
2	chr3:237600-241200	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
3	chr3:239200-243200	Active TSS	Fetal Brain Female	brain
4	chr3:240400-241200	Active TSS	Brain Germinal Matrix	brain
5	chr3:240400-241600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
6	chr3:240400-242200	Weak transcription	Cortex derived primary cultured neurospheres	brain
7	chr3:240400-242200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
8	chr3:240600-242000	Weak transcription	Pancreatic Islets	Pancreatic Islet
9	chr3:240600-243800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr3:241000-241200	Flanking Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
11	chr3:241000-241200	Flanking Active TSS	Fetal Brain Male	brain
12	chr3:241000-242400	Weak transcription	Brain Anterior Caudate	brain
13	chr3:241000-243400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr3:241200-241400	Enhancers	Brain Germinal Matrix	brain
15	chr3:241200-241600	Enhancers	Fetal Brain Male	brain
16	chr3:241400-242000	Weak transcription	Brain Germinal Matrix	brain
17	chr3:241600-241800	Enhancers	Breast Myoepithelial Primary Cells	Breast
18	chr3:241600-241800	Flanking Active TSS	Fetal Brain Male	brain
19	chr3:241800-242200	Enhancers	Fetal Brain Male	brain
20	chr3:242000-242200	Enhancers	Pancreatic Islets	Pancreatic Islet
21	chr3:242000-244800	Enhancers	Brain Germinal Matrix	brain
22	chr3:242200-242400	Flanking Active TSS	Fetal Brain Male	brain
23	chr3:242200-242600	Active TSS	Pancreatic Islets	Pancreatic Islet
24	chr3:242200-242800	Flanking Active TSS	Foreskin Melanocyte Primary Cells skin03	Skin
25	chr3:242200-243000	Enhancers	Cortex derived primary cultured neurospheres	brain
26	chr3:242400-242800	Active TSS	Fetal Brain Male	brain
27	chr3:242400-244400	Enhancers	Brain Anterior Caudate	brain
28	chr3:242600-242800	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
29	chr3:242800-243000	Flanking Active TSS	Fetal Brain Male	brain
30	chr3:242800-243000	Active TSS	Pancreatic Islets	Pancreatic Islet
31	chr3:242800-243600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
32	chr3:243000-243200	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
33	chr3:243000-244000	Weak transcription	Cortex derived primary cultured neurospheres	brain
34	chr3:243000-244400	Enhancers	Fetal Brain Male	brain
35	chr3:243200-245800	Weak transcription	Fetal Brain Female	brain
36	chr3:243400-244400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
37	chr3:243600-252000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
38	chr3:243800-244600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr3:244400-247200	Weak transcription	Fetal Brain Male	brain
40	chr3:244400-247600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr3:244400-254200	Weak transcription	Brain Anterior Caudate	brain
42	chr3:244600-245200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr3:244800-254200	Weak transcription	Brain Germinal Matrix	brain
44	chr3:245200-245400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
45	chr3:245400-252000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
46	chr3:245800-246000	Genic enhancers	Fetal Brain Female	brain
47	chr3:246000-246200	Enhancers	Fetal Brain Female	brain
48	chr3:246200-258600	Weak transcription	Fetal Brain Female	brain
49	chr3:247200-247600	Enhancers	Fetal Brain Male	brain
50	chr3:247600-247800	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links